| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |